Endoplasmic Reticulum stress in chronic kidney disease. New molecular targets from bench to the bedside

Carlo Alberto Ricciardi, Luigi Gnudi

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)

Abstract

The identification of new biomarkers/pharmacological targets for chronic kidney disease (CKD) is required for the development of more effective therapies. Several studies in vitro and in vivo have shown the importance of the endoplasmic reticulum (ER) (cellular organelle devolved to protein biosynthesis and maturation, and cellular detoxification processes) in the pathophysiology of CKD. Hence, the synthesis and development of novel drugs against the different ER intracellular pathways is crucial in order to slow down the development and progression of renal diseases. This review aims to dissect the role of the different ER branches (PERK, IRE1α, ATF6) and their function in CKD, providing potential insights for the development of new treatments.

Original languageEnglish
JournalGiornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
Volume36
Issue number6
Publication statusPublished - 9 Dec 2019

Keywords

  • chronic kidney disease
  • endoplasmic reticulum
  • reticulon
  • unfolded protein response

Fingerprint

Dive into the research topics of 'Endoplasmic Reticulum stress in chronic kidney disease. New molecular targets from bench to the bedside'. Together they form a unique fingerprint.

Cite this